Cambridge Healthtech Institute 第1回

Digital Therapeutics
( デジタルセラピューティクス )

根拠に基づく臨床的な検証を経たデジタルセラピューティクスと医療の統合

2020年6月2日~4日


デジタルセラピューティクスをテーマにしたこのカンファレンスプログラムでは、製薬会社やIT企業、主な研究機関や医療機関、規制機関、健康保険などの組織に所属するオピニオンリーダーが一堂に会し、デジタルセラピューティクスを患者に提供するための方策などについて議論します。

暫定版のアジェンダ

6月2日 (火)

全体セッション:医療分野でのデジタルトランスフォーメーション

Bringing Digital to Life: Transforming Healthcare and Patient Experience Using Human-Centered Design and Digital Solutions

Neil Gomes, MBA, Med, CSM, CSPO, Executive Vice President, Tech, Innovation & Consumer Experience, Enterprise Chief Digital Officer, Thomas Jefferson University & Jefferson Health

Driving Digital Transformation Success

Claus Jensen, PhD, Chief Digital Officer & Head of Technology, Memorial Sloan Kettering Cancer Center

Talk Title to be Announced

Joseph C. Kvedar, MD, Professor, Dermatology, Harvard Medical School; Senior Advisor, Virtual Care, Partners HealthCare

Delivering Digital Health in a Consumer Health World

Chet Robson, DO, MHCDS, FAAFP, Chief Clinical Officer, Walgreens

The Future of Health has Arrived: The Rise of Smart Health Communities

Asif Dhar, MD, MBA, Chief Health Informatics Officer, Principal, Deloitte Consulting LLP

処方箋に基づくデジタルセラピューティクスのための提携戦略

Prescription DTx

Alex Waldron, Chief Strategy Officer, Pear Therapeutics

PANEL DISCUSSION: Partnering Strategies for Digital Therapeutics

Moderator: Alex Waldron, Chief Strategy Officer, Pear Therapeutics


全体セッション:異なる専門領域間の連携:デジタルヘルスに対する統合化されたアプローチ

Commercialization, Regulatory and Partnering Strategies with Provider, Payers, Hub, Industry for Digital

Karan Arora, MBA, Chief Commercial Digital Officer, Global Vice President, AstraZeneca

PANEL DISCUSSION: An Integrated Approach to Data Silos, Collaboration and Patient-Centricity

 

6月3日 (水)

全体セッション:デジタルヘルス分野の技術革新

PANEL DISCUSSION: Investing in Digital Health Innovation

Moderator: Lisa Suennen, Lead, Digital & Technology Group, Manatt Ventures; Managing Director, Manatt Health
Panelists:
David Kim, Managing Director, DigiTx
Additional Panelists to be Announced

Delivering Global Comprehensive Virtual Care at Scale

Lewis Levy, MD, FACP, CMO, Teladoc

 

Additional Company Presentations to be Announced

疾病管理と処方薬服薬遵守のためのデジタルコンパニオン

Digital Therapeutics as Companion to Pharmaceuticals: Lessons Learned and Perspectives

Pierre Leurent, CEO, Voluntis

 

Additional Presentations to be Announced

デジタルセラピューティクスの商業化戦略:市場参入と価値モデル

Partnerships to Commercialize Digital Therapeutics

Adam Kaufman, PhD, President & CEO, Canary Health

Challenges and Potential Solutions in the Commercialization of Digital Therapeutics

David O'Reilly, Chief Platform Officer, Proteus Digital Health

PANEL DISCUSSION: Commercialization Strategies for Digital Therapeutics

Moderator: Adam Kaufman, PhD, President & CEO, Canary Health

 

6月4日 (木)

慢性疾患に対応する根拠に基づき個別化されたデジタルセラピューティクス

Beyond DTx - Engaging the Patient Holistically to Optimize Outcomes

Olivier Jarry, Chief Commercial Officer, President, DarioHealth Corp

Digital Therapeutics for Mental Health: Improving Outcomes, Access and Scale for Mental Healthcare

Ken Cahill, CEO, SilverCloud Health

全体セッション:根拠に基づくデジタルメディスン

Talk Title to be Announced

Ashish Atreja, MD, MPH, Assistant Professor, Chief Innovation Officer, Medicine, Icahn School of Medicine at Mount Sinai

PANEL DISCUSSION: Real World Impact of Digital Medicine

Moderator: Ashish Atreja, MD, MPH, Assistant Professor, Chief Innovation Officer, Medicine, Icahn School of Medicine at Mount Sinai



* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。

Choose your language
Traditional Chinese
Simplified Chinese
Korean
English





メール配信サービス